fluoxetine has been researched along with aspirin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bazex, J; Durand-Malgouyres, C; Marguery, MC | 1 |
| Harvey, AT; Lucot, JB; Shad, MU | 1 |
| Di Perri, T; Gaggelli, E; Laghi Pasini, F; Puccetti, L; Tassini, M; Valensin, G; Vivi, A | 1 |
| Alsenz, J; Birringer, C; Kuentz, M; Wyttenbach, N | 1 |
| Alboni, S; Benatti, C; Blom, JM; Brunello, N; Capone, G; Kriwin, P; Mendlewicz, J; Tascedda, F | 1 |
| Dingwall, K; Douglas, J; Jorgenson, G; Smith, SS | 1 |
| Bieńkiewicz, M; Gałecka, E; Gałecki, P; Szemraj, J; Zboralski, K | 1 |
| Gao, F; Jiang, W; Liu, YF; Wang, Y; Yang, F | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Andrade, C | 1 |
| Chen, C; Chen, H; Rui, BB; Wei, W; Xu, TJ; Xu, WP; Yang, JM | 1 |
| Chen, L; Guan, XT; Shao, F; Wang, W; Xie, X | 1 |
| Boiani, NF; Borrely, SI; Garcia, VSG; Silva, TT; Tominaga, FK | 1 |
2 review(s) available for fluoxetine and aspirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug interactions in the treatment of depression in patients with ischemic heart disease.
Topics: Aged; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Comorbidity; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Early Diagnosis; Fluoxetine; Fluvoxamine; Gastrointestinal Hemorrhage; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine | 2012 |
22 other study(ies) available for fluoxetine and aspirin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Aquagenic pruritus (A.P.)].
Topics: Acetylcholine; Age Factors; Aspirin; Bicarbonates; Fibrinolysis; Fluoxetine; Globulins; Histamine; Humans; Mast Cells; Pruritus; Sodium; Sodium Bicarbonate; Ultraviolet Rays; Water | 1990 |
A possible pharmacokinetic interaction between fluoxetine and acetylsalicylic acid.
Topics: Adult; Arthralgia; Aspirin; Depressive Disorder; Drug Hypersensitivity; Drug Interactions; Fluoxetine; Humans; Male; Urticaria | 1997 |
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study.
Topics: Aspirin; Blood Glucose; Blood Platelets; Carbohydrates; Fluoxetine; Humans; In Vitro Techniques; Lactic Acid; Magnetic Resonance Spectroscopy; Platelet Aggregation; Selective Serotonin Reuptake Inhibitors; Serotonin | 2002 |
Drug-excipient compatibility testing using a high-throughput approach and statistical design.
Topics: Aspirin; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Excipients; Fluoxetine; Hot Temperature; Humidity; Pharmaceutical Preparations; Time Factors | 2005 |
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Aspirin; Depression; Drug Synergism; Escape Reaction; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors | 2006 |
Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Antidepressive Agents; Aspirin; Drug Therapy; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Retrospective Studies; Sleep Apnea, Obstructive; Sleep, REM; Treatment Refusal | 2006 |
Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antioxidants; Aspirin; Depressive Disorder, Major; Drug Therapy, Combination; Fluoxetine; Humans; Lipid Peroxidation; Oxidative Stress; Psychiatric Status Rating Scales | 2009 |
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats.
Topics: Animals; Antidepressive Agents; Aspirin; Depression; Drug Therapy, Combination; Fluoxetine; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
Acetylsalicylic acid enhances the anti-inflammatory effect of fluoxetine through inhibition of NF-κB, p38-MAPK and ERK1/2 activation in lipopolysaccharide-induced BV-2 microglia cells.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Aspirin; Blotting, Western; Cell Line; Cell Survival; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Immunohistochemistry; Inflammation; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Signal Transduction | 2014 |
Effects of aspirin on immobile behavior and endocrine and immune changes in the forced swimming test: comparison to fluoxetine and imipramine.
Topics: Animals; Antidepressive Agents; Aspirin; Behavior, Animal; Corticosterone; Endocrine Glands; Fluoxetine; Imipramine; Immune System; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Swimming; Tumor Necrosis Factor-alpha | 2014 |
Acute and chronic ecotoxicological effects of pharmaceuticals and their mixtures in Daphnia similis.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Ciprofloxacin; Daphnia; Fluoxetine; Hypoglycemic Agents; Metformin; Pharmaceutical Preparations; Water; Water Pollutants, Chemical | 2022 |